We used CRISPR-Cas9 technology to knock out B7-H3 in PC3 and DU145 cells and then verified that B7-H3 CAR-T cells specifically recognize B7-H3 positive target cells and produce cytokines IFN-γ and TNF-α to induce tumor cell lysis in vitro. The gene discussed is CD276; the disease is neoplasm.